Synthesis and structure of oxovanadium(IV) complexes [VO(<Emphasis Type="Italic">Acac</Emphasis>)<Subscript>2</Subscript>] and [VO(<Emphasis Type="Italic">Sal</Emphasis>: <Emphasis Type="Italic">L</Emphasis>-alanine)(H<Subscript>2</Subscript>O)]

Bis(acetylacetonato)oxovanadium C₁₀H₁₄O₅V (I) and (S)-[2-(N-salicylidene)aminopropionate]oxovanadium monohydrate C₁₀H₉NO₅V (II) are synthesized. The crystal structures of compounds I and II are determined using single-crystal X-ray diffraction. Crystals of compound I are triclinic, a = 7.4997(19) Å, b = 8.2015(15) Å, c = 11.339(3) Å, α = 91.37(2)°, β = 110.36(2)°, γ = 113.33(2)°, Z = 2, and space group \(P\bar 1\). Crystals of compound II are monoclinic, a = 8.5106(16) Å, b = 7.373(2) Å, c = 9.1941(16) Å, β = 101.88(1)°, Z = 2, and space group P2₁. The structures of compounds I and II are solved by direct methods and refined to R₁ = 0.0382 and 0.0386, respectively. The oxovanadium complexes synthesized are investigated by vibrational spectroscopy.     

Synthesis,antityrosinase activity of curcumin analogues,and crystal structure of (1<Emphasis Type="Italic">E</Emphasis>,4<Emphasis Type="Italic">E</Emphasis>)-1,5-bis(4-ethoxyphenyl)penta-1,4-dien-3-one

Five derivatives of curcumin analogue (R = OCH₂CH₃ (1), R = N(CH₃)₂ (2), R = 2,4,5-OCH₃ (3), R = 2,4,6-OCH₃ (4), and R = 3,4,5-OCH₃ (5)) were synthesized and characterized by ¹H NMR, FT-IR and UV–Vis spectroscopy. The synthesized derivatives were screened for antityrosinase activity, and found that 4 and 5 possess such activity. The crystal structure of 1 was determined by single crystal X-ray diffraction: monoclinic, sp. gr. P2₁/c, a = 17.5728(15) Å, b = 5.9121(5) Å, c = 19.8269(13) Å, β = 121.155(5)°, Z = 4. The molecule 1 is twisted with the dihedral angle between two phenyl rings being 15.68(10)°. In the crystal packing, the molecules 1 are linked into chains by C?H···π interactions and further stacked by π···π interactions with the centroid–centroid distance of 3.9311(13) Å.     

Crystal structures of complexes of the <Emphasis Type="Italic">cys-syn-cys</Emphasis> isomer of dicyclohexano-18-crown-6 with oxonium hexafluorotantalate and oxonium hexafluoroniobate

The crystal structures of [(cys-syn-cys-dicyclohexano-18-crown-6 · H₃O)][TaF₆] and [(cys-syn-cys-dicyclohexano-18-crown-6 · H₃O)][NbF₆] complex compounds are determined using X-ray diffraction analysis. The tantalum complex has two polymorphic modifications, namely, the monoclinic (I) and triclinic (II) modifications. The unit cell parameters of these compounds are as follows: a = 8.507(4) Å, b = 11.947(5) Å, c = 27.392(12) Å, β = 93.11(1)°, Z = 4, and space group P2₁/n for modification I; and a = 10.828(1) Å, b = 11.204(1) Å, c = 12.378(1) Å, α = 72.12(1)°, β = 79.40(1)°, γ = 73.70(1)°, Z = 2, and space group P-1 for modification II. The triclinic niobium complex [(cys-syn-cys-dicyclohexano-18-crown-6 · H₃O)][NbF₆] (III) with the unit cell parameters a = 10.796(3) Å, b = 11.183(3) Å, c = 12.352(3) Å, α = 72.364(5)°, β = 79.577(5)°, γ = 73.773(4)°, Z = 2, and space group P-1 is isostructural with tantalum complex II. The structures of all three complexes are ionic in character. The oxonium cation in complexes I–III is encapsulated by the crown ether and thus forms one ordinary and two bifurcated hydrogen bonds with the oxygen atoms of the crown ether. This macrocyclic cation is bound to the anions through the C-H...F contacts (H...F, 2.48–2.58 Å). The conformation of the macrocycle in complex I differs substantially from that in complex II (III).     

Crystal Structure of Two <Emphasis Type="Italic">V</Emphasis>-shaped Ligands with <Emphasis Type="Italic">N</Emphasis>-Heterocycles

Two V-shaped ligands with N-heterocycles, bis(4-(1H-imidazol-1-yl) phenyl)methanone (1), and bis(4-(1H-benzo[d]imidazol-1-yl)phenyl)methanone (2) have been synthesized and characterized by elemental analyses, IR and 1H NMR spectroscopy. Crystal structures of 1 and 2 have been determined by X-ray diffraction. The crystal of 1 is monoclinic, sp. gr. P2₁/c, Z = 4. The crystal of 2 is orthorhombic, sp. gr. Fdd2, Z = 8. X-ray diffraction analyses show that the V-shaped angles of 1 and 2 are 122.72(15)° and 120.7(4)°, respectively. Intermolecular C–H···O, C–H···N, C–H···π, and π···π interactions link the components into three-dimensional networks in the crystal structures.     

The synthesis and crystal structure of (4<Emphasis Type="Italic">E</Emphasis>)-5(3-chlorophenyl)-<Emphasis Type="Italic">N</Emphasis>-(4-chlorophenyl)-2-diazo3-oxopent-4-enoic acid amide

(4E)-5-(3-Chlorophenyl)-N-(4-chlorophenyl)-2-diazo-3-oxopent-4-enoic acid amide (5) was synthesized from p-chloroaniline to N-(4-chlorophenyl)-2-diazo-3-oxo-butyramide (4) with 3-chlorobenzaldehyde. The yielded product 5 was investigated with X-ray crystallographic, NMR, MS, and IR techniques. Compound 5 (C₁₇H₁₁Cl₂N₃O₂, Formula wt = 360.19), crystallizes in the monoclinic space group P21/c with unit cell parameters a = 10.516(2), b = 17.996(4), c = 8.902(2) Å, α = 90.00, β = 105.36(3), γ = 90.00^°. V = 1624.5(6) ų, Z = 4, D _x = 1.473 Mg m^?3. The final R was 0.0511.     

X-ray crystal structures of two polymorphic forms,monoclinic and triclinic,of: 1-[(<Emphasis Type="Italic">E</Emphasis>)-2-(4-bromophenyl)1-diazenyl]-3-({3-[(<Emphasis Type="Italic">E</Emphasis>)-2-(4-bromophenyl)-1-diazenyl]-6-ethylhexahydro-1-pyrimidinyl}methyl)-4-ethylhexahydropyrimidine

1-[(E)-2-(4-bromophenyl)-1-diazenyl]-3-({3-[(E)-2-(4-bromophenyl)-1-diazenyl]-6-ethylhexahydro-1-pyrimidinyl}methyl)-4-ethylhexahydropyrimidine (1) has been synthesized by reaction of a mixture of formaldehyde and 1,3-pentanediamine{DYTEK^®EPdiamine} with p-bromobenzenediazonium chloride. This compound crystallizes in two polymorphic forms 1-α and 1-β whose crystal structures have been determined by single crystal X-ray diffraction analysis. Both polymorphs 1-α and 1-β display crystallographic disorder within the hexahydropyrimidine rings. The molecule of 1 is built up of two equivalent 3-(aryldiazenyl)-6-ethylhexahydro-1-pyrimidinyl groups in the s-trans orientation around the central methylene group (C13). In both structures the triazene moieties adopt the anti configuration around the N=N bonds, displaying significant π-conjugation. The crystal packings are determined only by van der Waals interactions. The crystal structures of 1-α and 1-β are compared with the previously reported structure of the 5,5-dimethylhexahydropyrimidine analogue 3. Compounds 1 and 3 are isomeric with respect to the hexahydropyrimidine moiety. The structures of 1 and 3 are very different in one respect; in 1 the aryldiazenyl-hexahydropyrimidinyl groups are in the s-trans orientation around the central methylene group, whereas in 3 the arrangement of the aryldiazenylhexahydropyrimidinyl groups is the s-cis orientation. Crystal data: 1-α C₂₅H₃₄N₈Br₂, monoclinic, space group P2(1)/c, a = 9.2150(3), b = 19.4059(6), c = 15.4324(5) Å, β = 98.738(1)^°, V = 2727.7(2) ų, for Z = 4; 1-β C₂₅H₃₄N₈Br₂, triclinic, space group P-1, a = 9.6009(3), b = 10.7509(4), c = 14.2169(5) Å, α = 99.830(2), β = 105.973(3), γ = 95.578(1)^°, V = 1373.9(1) ų, for Z = 2.     

X-ray mapping in heterocyclic design: VI. X-ray diffraction study of 3-(isonicotinoyl)-2-oxooxazolo[3,2-<Emphasis Type="Italic">a</Emphasis>]pyridine and the product of its hydrolysis

The structure of 3-(isonicotinoyl)-2-oxooxazolo[3,2-a]pyridine, C₁₃H₈N₂O₃, (I) is determined by X-ray powder diffraction analysis. Crystals I are orthorhombic, a = 16.610(2) Å, b = 3.853(1) Å, c = 16.431(2) Å, Z = 4, and space group Pna2₁. The structure is solved by the grid search procedure and refined by the Reitveld method (R_p = 0.086, R_wp = 0.115, R_e = 0.030, and χ² = 11.138). The structure of the product of hydrolysis of compound I, C₁₂H₁₀N₂O₂, (II) is determined by the single-crystal X-ray diffraction technique. Crystals II are orthorhombic, a = 8.755(4) Å, b = 10.526(17) Å, c = 23.088(6) Å, Z = 8, and space group Pc2₁b. The structure is solved by the direct method and refined by the full-matrix least-squares procedure to R = 0.0464. A fragment of two fused heterocycles in I is planar. The dihedral angle between the plane of the pyridine ring in the isonicotinoyl fragment and the plane of the bicyclic system is 51.2(2)°. Both exocyclic CO groups that are adjacent to the five-membered fragment contain double bonds. The structures of two crystallographically independent molecules II are almost identical to each other, and the isonicotinoyl fragment is nearly perpendicular to the plane of the pyridone fragment [84.3(1)° and 87.0(1)°].     

Synthesis of 2-arylidenebenzocycloalkanones containing <Emphasis Type="Italic">N</Emphasis>-donor heterocyclic rings

A series of 2-arylidenebenzocycloalkanones containing heterocyclic rings 1–8 were prepared and characterized by IR, ¹H NMR and elemental analyses. X-ray diffraction study of 6 reveals that the cyclohexyl ring of the 3,4-dihydronaphthalen-1(2H)-one adopts a chair conformation with a maximum deviation of 0.547(3) Å and makes dihedral angles of 52.24(17)° and 11.23(16)°, respectively, with the benzene plane and the mean plane of the benzimidazole ring.     

Synthesis,Characterization, and Crystal Structure of (2<Emphasis Type="Italic">E</Emphasis>)-3-(4-Fluorophenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one

The title chalcone, of formula C₁₅H₁₁F₁O_2, crystallized in the orthorhombic space group P2₁2₁2₁ (# 19) with crystal parameters a?=?6.9998(8) Å, b?=?12.6740(15) Å, c?=?12.8997(15) Å, V?=?1144.4(2) ų, Z?=?4, determined at 100 K with MoKα radiation. The solid-state structure displays an intramolecular S(6) hydrogen bond and the crystal architecture is maintained by intermolecular F?H, O?H, and C?C short contacts. A DFT geometry optimization is compared with the experimental structure. As ¹⁹F NMR spectroscopy can be used for metabolic tagging of biologically active compounds (including chalcones), the solution-state ¹⁹F chemical shift and ¹³C¹⁹F coupling constants (ⁿJ) are also reported.

Graphical Abstract

Open image in new window

     

X-Ray Crystal Structure of <Emphasis Type="Italic">trans</Emphasis>-PdCl<Subscript>2</Subscript>(PPh<Subscript>2</Subscript>C<Subscript>12</Subscript>H<Subscript>7</Subscript>S<Subscript>3</Subscript>)<Subscript>2</Subscript>, a New Morphology

Herein we report the crystal structure of trans-PdCl₂(PPh₂C₁₂H₇S₃)₂, 1, in a different morphology than has previously been reported [Stott et al. (Dalton Trans (4):652–653, 2005]. This structure crystallizes in a P-1 space group with a = 9.4249(19) Å, b = 11.540(2) Å, c = 12.559(3) Å, α = 79.07(3)°, β = 78.04(3)°, γ = 69.44(3)°, Z = 1. The earlier structure possessed a P2₁/n space group. Additionally the terthienyl moieties of 1 demonstrate the anti orientation exclusively while the P2₁/n space group structure has some syn and even syn/anti mixed geometries included.     

X-ray mapping in heterocyclic design: XV. Tricyclic heterocycles based on 2-oxo-2,5,6,7-tetrahydro-1<Emphasis Type="Italic">H</Emphasis>-cyclopenta[<Emphasis Type="Italic">b</Emphasis>]pyridine-3-carbonitrile

The structures of five compounds are studied using single-crystal X-ray diffraction: 2-oxo-2,5,6,7-tetrahydro-1H-cyclopenta[b]pyridine-3-carbonitrile [a = 15.641(8) Å, b = 9.373(5) Å, c = 7.387(4) Å, β = 92.91(5)°, Z = 4, space group P2₁/c]; 1-[2-(4-chlorophenyl)-2-oxoethyl]-2-oxo-2,5,6,7-tetrahydro-1H-cyclopenta[b]pyridine-3-carbonitrile [a = 4.728(4) Å, b = 28.035(11) Å, c = 11.184(3) Å, Z = 4, space group P2₁2₁2₁]; 2-[2-(4-chlorophenyl)-2-oxoethoxy]-6,7-dihydro-5H-cyclopenta[b]pyridine-3-carbonitrile [a = 10.1202(13) Å, b = 11.2484(18) Å, c = 13.4323(19) Å, β = 102.05(1)°, Z = 4, space group P2₁/c]; 2-(4-chlorophenyl)-3a, 6,7,8-tetrahydrocyclopenta[e][1.3]oxazolo[3.2-a]pyridine-4-carboxamide perchlorate [a = 7.702(2) Å, b = 9.599(3) Å, c = 23.798(5) Å, β = 93.44(2)°, Z = 4, space group P2₁/c]; and (3-amino-6,7-dihydro-5H-cyclopenta[b]furo[3.2-e]pyridin-2-yl)(4-chlorophenyl)methanone [a = 7.3273(2) Å, b = 13.390(3) Å, c = 28.792(8) Å, Z = 8, space group Pbca]. The structures are solved using direct methods and refined by the full-matrix least-squares procedure in the anisotropic approximation to R = 0.0580, 0.0724, 0.0469, 0.0477, and 0.0418, respectively.     

Synthesis and structural characterization of a Cu(I) complex with 4-(1<Emphasis Type="Italic">H</Emphasis>-imidazol-1-yl)phenyl)methanone ligands

A copper complex with V-shaped ligands, [(L¹)Cu₂Cl₂] _n (1), (L1 = 4-(1H-imidazol-1-yl)phenyl) methanone) has been synthesized and characterized by IR spectroscopy, elemental analyses and singlecrystal X-ray diffraction. The crystal of 1 is monoclinic, sp. gr. C2/_c with the unit cell parameters a = 17.9496(13), b = 15.3440(13), c = 7.2983(7) Å, and β = 112.875(6)°, Z = 4, R₁ = 0.0681, and wR₂ = 0.1736 (I > 2 σ). The solid state structure of 1 consists of 2D metal aromatic chloride layers, which are propagating along the bc plane to form a 3D network through hydrogen bonds.     

Crystal structure of <Emphasis Type="Italic">p</Emphasis>-carboxyphenylhydrazone benzoylacetone

The crystal structure of p-carboxyphenylhydrazone benzoylacetone is determined. The crystals are monoclinic, a = 13.614(4) Å, b = 11.388(2) Å, c = 20.029(6) Å, β = 104.82(2)°, V = 2339(9) ų, Z = 8, space group C2/c, and R = 0.038 for 1622 reflections with I > 2σ(I). The crystal is built of C₁₇H₁₄N₂O₄ neutral molecules that are linked by O-H?O hydrogen bonds between the carboxyl groups into centrosymmetric pseudodimers. The effect of carboxylation of the phenylhydrazone fragment and the position of the carboxyl group on the molecular packing in the crystal is determined. The N(1)-H(1N)?O(1) intramolecular hydrogen bond (N-H, 0.94 Å; H?O, 1.87 Å; N?O, 2.59 Å; and the N-H?O angle, 133°) is formed in the molecule.     

Complexes of Ambidentate N,O-Donor Ligands with Rhenium(I) and -(V)

The reaction of the potentially bidentate ambidentate N,O-donor ligands 3-hydroxy-2-pyridinecarboxylic acid (Hhpc) and 3-hydroxy-2-(hydroxymethyl)pyridine (Hhhp) with trans-[ReOCl₃(PPh₃)₂] led to the isolation of the products [ReOCl(hpc)₂] (1) (from acetonitrile) and [ReOCl₂(hhp)(PPh₃)] (2) (from ethanol) respectively. In both complexes hpc and hhp are coordinated as bidentate N,O-donor chelates, rather than as O,O-donor ligands. From the reaction of [Re(CO)₅Cl] and Hhhp·HCl in ethanol the neutral complex fac-[Re(CO)₃Cl(Hhhp)] (3) was obtained, with N,O-coordination of Hhhp. Complex 1 crystallizes in the monoclinic space group P2₁/n with a?=?6.8782(3), b?=?20.0647(8), c?=?10.8692(4) Å, β?=?107.545(1)°, and Z?=?4. Complex 2 crystallizes in the triclinic space group P-1 with a?=?7.3523(4), b?=?8.1047(5), c?=?19.591(1) Å, α?=?91.133(2)°, β?=?93.656(2)°, γ?=?93.074(2)° and Z?=?2. Complex 3 has monoclinic P2₁/c symmetry with the cell parameters a?=?10.6452(5), b?=?11.1372(5), c?=?9.7229(5) Å, β?=?106.107(2)°, and Z?=?4.

Graphical Abstract

The reaction of the potentially bidentate ambidentate N,O-donor ligands 3-hydroxy-2-pyridinecarboxylic acid (Hhpc) and 3-hydroxy-2-(hydroxymethyl)pyridine (Hhhp) with trans-[ReOCl₃(PPh₃)₂] led to the isolation of the products [ReOCl(hpc)₂] (from acetonitrile) and [ReOCl₂(hhp)(PPh₃)] (from ethanol) respectively. In both complexes hpc and hhp are coordinated as bidentate N,O-donor chelates, rather than as O,O-donor ligands. From the reaction of [Re(CO)₅Cl] and Hhhp·HCl in ethanol the neutral complex fac-[Re(CO)₃Cl(Hhhp)] was obtained, with N,O-coordination of Hhhp. Spectroscopic data and the X-ray crystal structures of the complexes are reported.

Open image in new window

     

X-ray mapping in heterocyclic design: 16. X-ray diffraction study of 1-(4-chlorophenacyl)-4-methyl-1,5,6,7-tetrahydro-2<Emphasis Type="Italic">H</Emphasis>-cyclopenta[<Emphasis Type="Italic">b</Emphasis>]pyridin-2-one

The structure of 1-(4-chlorophenacyl)-4-methyl-1,5,6,7-tetrahydro-2H-cyclopenta[b]pyridin-2-one is studied using single-crystal X-ray diffraction. The structure (a = 37.006(8) Å, b = 8.967(3) Å, c = 27.911(3) Å, β = 96.52(2)°, Z = 24, space group P2₁/c) is solved by direct methods and refined to R₁ = 0.0608 and wR₂ = 0.1170. Six crystallographically independent molecules differ in the dihedral angle between the phenyl and heterocycle planes. The formation of Cl?Cl aggregates is discussed.     

Crystal structure of <Emphasis Type="Italic">L</Emphasis>-serine phosphate

The crystal structure of L-serine phosphate (C₃O₃NH₇ · H₃PO₄) is determined by single-crystal X-ray diffraction. The unit cell parameters are as follows: a = 9.134(5) Å, b = 9.489(5) Å, c = 4.615(5) Å, γ = 99.54(5)°, space group P2₁, and Z = 2. The amino group of serine is protonated by a hydrogen atom of the phosphoric acid. The H₂PO ₄ ^1? ions are linked by hydrogen bonds into infinite ribbons aligned along the twofold screw axes. The ribbons form layers alternating with layers of serine molecules, which are directly linked by hydrogen bonds.     

Crystal structure analysis of 4-phenylquinolin-2-(1<Emphasis Type="Italic">H</Emphasis>)-one

The crystal structure of 4-phenylquinolin-2-(1H)-one (C₁₅H₁₁NO) is determined by X-ray diffraction. The compound crystallizes in the orthorhombic crystal system (space group Pbca) with the unit cell parameters a = 7.382(2) Å, b = 21.795(3) Å, c = 14.066(5) Å, and Z = 8. The structure is solved by direct methods and refined to an R-value of 0.0398 for 1360 observed reflections [F₀ > 4σ (F₀)]. The quinoline moiety and the substituted phenyl ring are nearly planar. The dihedral angle between these two moieties is 64.65(6)°. The crystal structure is stabilized by two intermolecular N-H?O and C-H?O interactions.     

X-ray and neutron diffraction studies of Rb<Subscript>4</Subscript>LiH<Subscript>3</Subscript>(XO<Subscript>4</Subscript>)<Subscript>4</Subscript><Emphasis Type="Italic">(X</Emphasis> = S,Se) single crystals

Rb₄LiH₃(SeO₄)₄ single crystals (1) are studied by the X-ray diffraction method at 180 K and Rb₄LiH₃(SO₄)₄ single crystals (2a–2c) are studied by the neutron diffraction method at 298 K (2a and (2b) and 480 K (2c). It is established that isostructural single crystals 1 and 2 (sp. gr. P4₁) have analogous systems of hydrogen bonds: chains of four XO₄ tetrahedra linked by three H bonds with the central bond (2.49 Å) being somewhat shorter than the terminal ones (2.52–2.54 Å). In the high-temperature 2c phase, the amplitudes of atomic thermal vibrations and the degree of proton disorder in the central hydrogen bond have somewhat elevated values.     

X-ray crystallography of methyl (6-amino-5-cyano-2-methyl-4-(2-nitrophenyl)-4<Emphasis Type="Italic">H</Emphasis>-pyran)-3-carboxylate

The organic carbonitrile namely methyl (6-amino-5-cyano-2-methyl-4-(2-nitrophenyl)-4H-pyran)- 3-carboxylate is synthesized via one-pot multi-component reaction at room temperature using commercially available urea as inexpensive and environmentally benign organo-catalyst and its crystal structure is determined by X-ray technique. The crystals are monoclinic, sp. gr. C2/c, a = 12.3069(8) Å, b = 9.7023(7) Å, c = 24.812(2) Å, β = 94.862(6)°, Z = 8. The dihedral angle between pyran and phenyl rings is 87.8(1)°; the pyran ring is almost planar The dihedral angle between the mean planes of phenyl ring and nitro group is 44.4(2)°. The crystal structure is stabilized by N?H···N and N?H···O hydrogen bonds. In addition, C?H···π interactions are also observed in the crystal structure.     

Crystal structure of <Emphasis Type="Italic">L</Emphasis>-alanine phosphate

The crystal structure of L-alanine phosphate (C₃O₂NH₇ · H₃PO₄) is determined by the single-crystal diffraction technique; a = 11.918(1) Å, b = 9.117(1) Å, c = 7.285(1) Å, γ = 104.7(1)°, space group P2₁, and Z = 4. The amino group of the alanine is protonated by the hydrogen atom of the phosphoric acid. Pairs of H₂PO ₄ ^? hydrogen-bonded ions are packed into layers alternating with layers of alanine molecules in the crystal. No hydrogen bonds are formed immediately between the alanine molecules.